Overexpression of Mcl-1L splice variant is associated with poor and prognosis chemoresistance in oral cancers

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Palve, Vinayak ^a   Mallick, Nchita ^a   Ghaisas, Gauri ^a   Kannan, Sadhana ^a   Teni, Tanuja ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MESSENGER RNA; OBATOCLAX; PROTEIN MCL 1; ANTINEOPLASTIC AGENT; ISOPROTEIN; MCL1 PROTEIN, HUMAN; PYRROLE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RESISTANCE; CANCER SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MCL 1ES GENE; MCL 1L GENE; MCL 1S GENE; MOUTH CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL PREDICTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING; ALTERNATIVE RNA SPLICING; DRUG POTENTIATION; DRUG RESISTANCE; GENETICS; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; TUMOR CELL LINE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; PROGNOSIS; PROTEIN ISOFORMS; PYRROLES; YOUNG ADULT;

EID: 84913554608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111927     Document Type: Article

References (46)

1. Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, et al. (2012) Cancer mortality in India: a nationally representative survey. Lancet 379: 1807-1816.
2. Coelho KR (2012) Challenges of the oral cancer burden in India. Journal of cancer epidemiology 2012.
3. Reed JC (1999) Dysregulation of apoptosis in cancer. Journal of Clinical Oncology 17: 2941-2941.
4. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-ordeath switch. Nature Reviews Cancer 2: 647-656.
5. Craig R (2002) MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis. Leukemia: official journal of the Leukemia Society of America, Leukemia Research Fund, UK 16: 444.
6. Thomas LW, Lam C, Edwards SW (2010) Mcl-1; the molecular regulation of protein function. FEBS letters 584: 2981-2989.
7. Willis SN, Chen L, Dewson G, Wei A, Naik E, et al. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes & development 19: 1294-1305.
8. Akgul C (2009) Mcl-1 is a potential therapeutic target in multiple types of cancer. Cellular and molecular life sciences 66: 1326-1336.
9. Nagata M, Wada K, Nakajima A, Nakajima N, Kusayama M, et al. (2009) Role of myeloid cell leukemia-1 in cell growth of squamous cell carcinoma. Journal of pharmacological sciences 110: 344-353.
10. O'Driscoll, Cronin D, Kennedy S, Purcell R, Linehan R, et al. (2004) Expression and prognostic relevance of Mcl-1 in breast cancer. Anticancer research 24: 473-482.
11. Likui W, Qun L, Wanqing Z, Haifeng S, Fangqiu L, et al. (2009) Prognostic role of myeloid cell leukemia-1 protein (Mcl-1) expression in human gastric cancer. Journal of surgical oncology 100: 396-400.
12. Zhang T, Zhao C, Luo L, Zhao H, Cheng J, et al. (2012) The expression of Mcl- 1 in human cervical cancer and its clinical significance. Medical Oncology 29: 1985-1991.
13. Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, et al. (2002) Increased MCL-1 Expression Is Associated with Poor Prognosis in Ovarian Carcinomas. Cancer Science 93: 542-550.
14. Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, et al. (2009) Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1. The Journal of pathology 217: 398-407.
15. Mallick S, Agarwal J, Kannan S, Pawar S, Kane S, et al. (2010) PCNA and antiapoptotic Mcl-1 proteins predict disease-free survival in oral cancer patients treated with definitive radiotherapy. Oral oncology 46: 688-693.
16. Kim J-H, Sim S-H, Ha H-J, Ko J-J, Lee K, et al. (2009) MCL-1ES, a novel variant of MCL-1, associates with MCL-1L and induces mitochondrial cell death. FEBS letters 583: 2758-2764.
17. Palve VC, Teni TR (2012) Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells. Radiation Oncology 7: 1-11.
18. Yang C, Kaushal V, Shah SV, Kaushal GP (2007) Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells. American Journal of Physiology-Renal Physiology 292: F1710-F1717.
19. Simonin K, Brotin E, Dufort S, Dutoit S, Goux D, et al. (2009) Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Molecular cancer therapeutics 8: 3162-3170.
20. Zhang H, Guttikonda S, Roberts L, Uziel T, Semizarov D, et al. (2010) Mcl-1 is critical for survival in a subgroup of non-small-cell lung cancer cell lines. Oncogene 30: 1963-1968.
21. Nguyen M, Marcellus RC, Roulston A, Watson M, Serfass L, et al. (2007) Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1- mediated resistance to apoptosis. Proceedings of the National Academy of Sciences 104: 19512-19517.
22. Quinn BA, Dash R, Azab B, Sarkar S, Das SK, et al. (2011) Targeting Mcl-1 for the therapy of cancer. Expert opinion on investigational drugs 20: 1397-1411.
23. Park HR, Kim SH, Lee SY, Sung JM, Park AR, et al. (2011) Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 117: 1864-1873.
24. Rheinwald JG, Beckett MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer research 41: 1657-1663.
25. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, et al. (2008) Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral oncology 44: 369-382.
26. Tatake RJ, Rajaram N, Damle R, Balsara B, Bhisey A, et al. (1990) Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors. Journal of cancer research and clinical oncology 116: 179-186.
27. Raul U, Sawant S, Dange P, Kalraiya R, Ingle A, et al. (2004) Implications of cytokeratin 8/18 filament formation in stratified epithelial cells: induction of transformed phenotype. Int J Cancer 111: 662-668.
28. Chang SE, Foster S, Betts D, Marnock WE (1992) DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed nonmalignant phenotype. International journal of cancer 52: 896-902.
29. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, et al. (2008) Chromosomal imbalances in oral squamous cell carcinoma. Examination of 31 cell lines and review of the literature. Oral oncology 44: 369.
30. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101-1108.
31. Kempkensteffen C, Hinz S, Johannsen M, Krause H, Magheli A, et al. (2009) Expression of Mcl-1 splicing variants in clear-cell renal cancer and their correlation with histopathological parameters and prognosis. Tumor Biology 30: 73-79.
32. Luo L, Zhang T, Liu H, Lv T, Yuan D, et al. (2012) MiR-101 and Mcl-1 in non-small- cell lung cancer: expression profile and clinical significance. Medical Oncology 29: 1681-1686.
33. Bae J, Leo CP, Hsu SY, Hsueh AJ (2000) MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain. J Biol Chem 275: 25255-25261.
34. Zhang T, Zhao C, Luo L, Zhao H, Cheng J, et al. (2012) The expression of Mcl- 1 in human cervical cancer and its clinical significance. Medical Oncology: 1-7.
35. Pepper C, Lin TT, Pratt G, Hewamana S, Brennan P, et al. (2008) Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers. Blood 112: 3807-3817.
36. Lestini BJ, Goldsmith KC, Fluchel MN, Liu X, Chen NL, et al. (2009) Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists. Cancer biology & therapy 8: 1587-1595.
37. Chetoui N, Sylla K, Gagnon-Houde J-V, Alcaide-Loridan C, Charron D, et al. (2008) Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis. Molecular Cancer Research 6: 42-52.
38. Schulze-Bergkamen H, Fleischer B, Schuchmann M, Weber A, Weinmann A, et al. (2006) Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction. BMC cancer 6: 232.
39. Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, et al. (2006) Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. Journal of hepatology 44: 151-157.
40. Liping S, Ying W, Mingzhen X, Yuan L, Lei Y (2010) Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 110: 484-491.
41. Tsai LL, Yu CC, Chang YC, Yu CH, Chou MY (2011) Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine 40: 621-628.
42. Hamada T (2014) Expression of MUC4 is correlated with chemoresistance and survival in oral squamous cell carcinoma. 2014 Annual Meeting. Aaoms.
43. Liu X, Deng L, Zhang H, Zeng T, Wang H, et al. (2014) Secretory Kin17 is Correlated with Chemoresistance in Oral Squamous Cell Carcinoma. Journal of Analytical Oncology 3: 18-25.
44. Chen S, Dai Y, Harada H, Dent P, Grant S (2007) Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer research 67: 782-791.
45. Peter B, Cerny-Reiterer S, Hadzijusufovic E, Schuch K, Stefanzl G, et al. (2013) The pan-Bcl-2 blocker obatoclax promotes the expression of Puma, Noxa, and Bim mRNA and induces apoptosis in neoplastic mast cells. Journal of leukocyte biology.
46. Yazbeck VY, Li C, Grandis JR, Zang Y, Johnson DE (2014) Single-agent obatoclax (GX15-070) potently induces apoptosis and pro-survival autophagy in head and neck squamous cell carcinoma cells. Oral oncology 50: 120-127.